Cognition Therapeutics CGTX
NASDAQ CGTX
$0.93 +0.04 (+4.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cognition Therapeutics (CGTX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Cognition Therapeutics (CGTX) reported Return on Capital Employed [ROCE] of -114.14% for Q2 2026, up 461.48 percentage points from -575.61% a year earlier and up 4.17 percentage points from the prior quarter.

Analysis

Cognition Therapeutics (CGTX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Cognition Therapeutics posted Return on Capital Employed [ROCE] of -188.27%, up 62.07 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of -75.08 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -250.35% in FY2024 (-94.87 pp), -155.48% in FY2023 (-62.79 pp), -92.69% in FY2022 (+20.51 pp) and -113.20% in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q1 2023.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last four quarters, with an average year-over-year change of +25.32 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2026 (a gain of 461.48 percentage points); the low point was Q2 2025 (a drop of 347.06 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -118.31% (Q1 2026), -149.52% (Q4 2025) and -180.45% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Cognition Therapeutics 88.40 Mn 88.40 Mn - -114.14%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -114.14%
Mar 31, 2026 -118.31%
Dec 31, 2025 -149.52%
Sep 30, 2025 -180.45%
Jun 30, 2025 -575.61%
Mar 31, 2025 -336.99%
Dec 31, 2024 -303.79%
Sep 30, 2024 -319.84%
Jun 30, 2024 -228.55%
Mar 31, 2024 -203.07%
Dec 31, 2023 -189.28%
Sep 30, 2023 -144.09%
Jun 30, 2023 -123.66%
Mar 31, 2023 -97.80%
Dec 31, 2022 -90.80%
Sep 30, 2022 -96.72%
Jun 30, 2022 -66.05%
Mar 31, 2022 -54.48%
Dec 31, 2021 -64.43%
API Access

Cognition Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CGTX&period=max&api_key=YOUR_API_KEY